Mariner’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
Mariner's IHE Position: Q1 2026 in Review
Mariner reduced its iShares US Pharmaceuticals ETF (IHE) stake by 1.8% in Q1 2026, selling an estimated $39K and leaving 24,922 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.
Mariner first reported a position in IHE in Q3 2016 and has held it in 18 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- Mariner held 24,922 shares of iShares US Pharmaceuticals ETF worth $2.16M as of Q1 2026.
- Mariner sold 445 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $39K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #1485 holding.
- Mariner first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and has held it in 18 quarters since.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.